SCHEMBL14070845

SCHEMBL14070845

Nc1nc2ccc(-c3ncc(F)c(N4CCCC4C(=O)NCC(F)(F)F)n3)cc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.41
PIK3CD O00329 7/20 0.40
PIK3CG P48736 7/20 0.40
PIK3CB P42338 5/20 0.40
AADAT Q8N5Z0 5/20 0.39
PI4KA P42356 7/20 0.37
PI4KB Q9UBF8 7/20 0.37
GUCY1B2 O75343 1/20 0.37
GUCY1A2 P33402 1/20 0.37
GUCY1A1 Q02108 1/20 0.37
GUCY1B1 Q02153 1/20 0.37
LMNA P02545 1/20 0.37
PIP5K1C O60331 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10044671 1.00 PIK3CA (0.41) PIK3CAPIK3CDPIK3CGPIK3CBAADAT
SCHEMBL10044695 0.88 PIK3CA (0.43) PIK3CAPIK3CDPIK3CGPIK3CBCYP3A4
SCHEMBL10044738 0.87 DYRK2 (0.40) AADATGUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL10044809 0.86 GUCY1B2 (0.40) AADATGUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL10044645 0.86 PIK3CA (0.42) PIK3CAPIK3CDPIK3CGPIK3CBAADAT
SCHEMBL10044690 0.83 GSK3B (0.41) AADATGUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL13305968 0.82 GUCY1B2 (0.40) AADATGUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL10044600 0.82 GUCY1B2 (0.40) AADATGUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL10044608 0.82 GUCY1B2 (0.40) AADATGUCY1B2GUCY1A2GUCY1A1GUCY1B1
SCHEMBL10044674 0.81 GUCY1B2 (0.42) AADATGUCY1B2GUCY1A2GUCY1A1GUCY1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008116139-A2 N-HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-09-25 WO disclosed